Price Alert

Achieve Life Sciences Inc... (ACHV)

NASDAQ: ACHV · Real-Time Price · USD

2.58

0.01 (0.39%)

At close: Aug 20, 2025, 10:05 AM

0.39% (1D)

Bid	n/a
Market Cap	132.11M
Revenue (ttm)	n/a
Net Income (ttm)	-46.16M
EPS (ttm)	-1.48
PE Ratio (ttm)	-1.75
Forward PE	-2.32
Analyst	Strong Buy

Ask	n/a
Volume	69,219
Avg. Volume (20D)	954,677
Open	2.59
Previous Close	2.57
Day's Range	2.54 - 2.59
52-Week Range	1.84 - 5.31
Beta	1.31

About ACHV

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol ACHV

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ACHV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

1 month ago

-36.47%

Achieve Life Sciences shares are trading lower aft... Unlock content with Pro Subscription

1 month ago

-7.63%

Achieve Life Sciences shares are trading lower after the company announced a proposed underwritten public offering.

News

1 week ago · seekingalpha.com

Achieve Life Sciences, Inc. (ACHV) Q2 2025 Earnings Call Transcript

Achieve Life Sciences, Inc. (NASDAQ:ACHV ) Q2 2025 Earnings Call August 7, 2025 8:30 AM ET Company Participants Cindy Jacobs - Former President & Chief Medical Officer Jaime Xinos - Chief Commercial O...

1 week ago · fool.com

Achieve (ACHV) Q2 Net Loss Hits $12.7M

1 month ago · seekingalpha.com

Achieve Life Sciences: Nearing Commercialization Of A Best-In-Class Pharmaceutical Product For Smoking Cessation

ACHV's cytisinicline shows best-in-class efficacy and safety for smoking cessation, supported by strong clinical data and recent NDA submission. The target market is large, with millions seeking smoki...

2 months ago · https://www.defenseworld.net

Squarepoint Ops LLC Buys Shares of 17,519 Achieve Life Sciences, Inc. (NASDAQ:ACHV)

Squarepoint Ops LLC bought a new stake in shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing...

2 months ago · seekingalpha.com

Achieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies Risk

Achieve Life Sciences (ACHV) is positioned for growth with its lead smoking cessation therapy, cytisinicline, advancing through late-stage clinical trials. The company addresses a significant unmet ne...